Redox biomarker levels in patients with myelodysplastic syndrome
Biomedical Reports · 14.01.2025 · 22 (3)
DOI: 10.3892/br.2025.1923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Reports, online erschienen am 14.01.2025. Verfasst von Eleni Tsiara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Viopolis, Mezourlo, Larissa 41110, Greece. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Viopolis, Mezourlo, Larissa 41110, Greece.
- Department of Biochemistry and Biotechnology, University of Thessaly, Viopolis, Mezourlo, Larissa 41500, Greece.
Zitieren
APA
Tsiara, E., Makri, S., Skaperda, Z., Giannakoulas, N., Vasilopoulos, G., & Kouretas, D. (2025). Redox biomarker levels in patients with myelodysplastic syndrome. Biomedical Reports, 22(3). https://doi.org/10.3892/br.2025.1923
Vancouver
Tsiara E, Makri S, Skaperda Z, Giannakoulas N, Vasilopoulos G, Kouretas D. Redox biomarker levels in patients with myelodysplastic syndrome. Biomedical Reports. 2025;22(3). doi:10.3892/br.2025.1923
BibTeX
@article{Tsiara2025,
author = {Tsiara, Eleni and Makri, Sotiria and Skaperda, Zoi and Giannakoulas, Nikolaos and Vasilopoulos, George and Kouretas, Demetrios},
title = {Redox biomarker levels in patients with myelodysplastic syndrome},
journal = {Biomedical Reports},
year = {2025},
volume = {22},
number = {3},
doi = {10.3892/br.2025.1923}
}
EUVIMED